Affimed (NASDAQ:AFMD) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. HC Wainwright restated a buy rating and issued a $5.00 price objective on shares […]
More Stories
Annaly Capital Management Inc (NYSE:NLY) Given Average Recommendation of “Moderate Buy” by Analysts
Annaly Capital Management Inc (NYSE:NLY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the...
Renewal Fuels (OTCMKTS:RNWF) vs. Origin Materials (NASDAQ:ORGN) Head-To-Head Survey
Origin Materials (NASDAQ:ORGN – Get Free Report) and Renewal Fuels (OTCMKTS:RNWF – Get Free Report) are both energy companies, but...
Dycom Industries (NYSE:DY) vs. China Communications Construction (OTCMKTS:CCCGY) Head to Head Contrast
China Communications Construction (OTCMKTS:CCCGY – Get Free Report) and Dycom Industries (NYSE:DY – Get Free Report) are both construction companies,...
Head-To-Head Contrast: Loma Negra Compania Industrial Argentina (LOMA) vs. The Competition
Loma Negra Compania Industrial Argentina (NYSE:LOMA – Get Free Report) is one of 23 publicly-traded companies in the “BLDG –...
Reviewing Shimano (SMNNY) & The Competition
Insider and Institutional Ownership 0.0% of Shimano shares are owned by institutional investors. Comparatively, 54.2% of shares of all “LEISURE&REC...
Avrupa Minerals (CVE:AVU) Trading Up 33.3% – Time to Buy?
Avrupa Minerals Ltd. (CVE:AVU – Get Free Report) traded up 33.3% during mid-day trading on Saturday . The stock traded...